The Telomerase Inhibitor Imetelstat Alone, and in Combination With Trastuzumab, Decreases the Cancer Stem Cell Population and Self-Renewal of HER2+ Breast Cancer Cells
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-015-3270-1
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2015
Authors
Publisher
Springer Science and Business Media LLC